Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 3,000 shares at $1.62 ($5K) on 2009-01-30, disclosed to the SEC on 2009-02-03.
Open-market purchase of $5k BCRX by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |